We have used glucose sensors for our patients with RH when pharmacological interventions have reached their ceiling effect, although this is currently off-label ( We acknowledge limitations to our conclusions resulting from the case series design
14,16 In the brain, GLP-1RAs bind to receptors in the hypothalamus to promote satiety and reduce food intake
Trial FLOW (Perkovic et al., NEJM 2024) Design Phase 3 / event-driven Population 3,533 adults with T2D and CKD Key result 24% reduction in kidney disease progression and CV death (HR 0.76
This persistent risk has been attributed to additional factors, such as triglyceride-rich lipoproteins, remnant cholesterol, lipoprotein(a), and chronic inflammation
Your provider must screen for these conditions comprehensively